BIOCEPT INC BIOC Cash Flow

Biocept inc (BIOC)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Cash Flows from Operating Activities
Net loss
-27,562	-25,138	-25,438	-25,794	-24,131	-24,571	-24,224	-23,998	-23,537	-21,613	-20,134	-19,055	-17,956	-18,399	-18,829	-18,583	-18,023	-16,949	-16,213	-15,577	-14,538	-15,866	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
952	931	911	894	843	800	761	706	639	575	469	390	360	322	320	304	285	261	261	253	246	251	0	0	0
Amortization of right-of-use assets
-169	-158	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory reserve
-38	-14	-74	-39	23	38	120	90	35	50	13	22	47	31	54	57	49	34	0	0	0	-	-	-	-
Inventory reserve
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Stock-based compensation
910	869	736	551	500	623	527	889	1,099	1,247	1,661	1,650	1,598	1,593	1,526	1,400	1,412	1,377	1,332	1,314	1,261	1,822	0	0	0
Non-cash interest expense related to credit facility and other financing activities
-	-	-	-	-	29	51	70	60	45	63	73	78	100	87	84	115	119	110	117	90	1,445	0	0	0
Warrant inducement expense
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	200	0	0	0
Increase/(decrease) in cash resulting from changes in:
Accounts receivable, net
1,541	1,952	1,385	771	548	380	343	442	494	1,064	1,047	908	791	94	45	54	27	23	27	3	-10	1	0	0	0
Inventory
380	194	179	107	63	50	-314	-184	-69	-100	264	112	110	168	140	184	103	126	128	90	104	82	0	0	0
Prepaid expenses and other current assets
-234	-523	-533	-662	-843	-488	-365	-358	-221	-518	-424	-450	-599	-494	-602	-497	-367	80	53	170	463	401	0	0	0
Accounts payable
275	14	-10	94	550	601	255	119	218	349	-150	635	404	332	798	358	-124	-51	152	-163	185	-981	0	0	0
Accrued liabilities
228	210	40	109	320	460	62	103	278	236	684	533	423	165	175	-106	268	240	349	394	407	-1,046	0	0	0
Accrued interest
-	-	-	-	-	-	-	-	-	-	-	-	-	55	72	95	104	110	0	0	0	-	-	-	-
Deferred rent
-	-	-	-	-	-116	-106	-96	-86	-76	-66	-56	-46	-36	-27	-17	-8	1	10	19	28	38	0	0	0
Net cash used in operating activities
-23,080	-23,049	-22,995	-22,842	-22,026	-22,355	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Flows from Investing Activities:
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-15,478	-15,697	-15,516	-16,263	-15,782	-15,154	-14,114	-13,832	-12,812	-14,575	0	0	0
Purchases of fixed assets
720	735	297	159	124	145	489	945	1,326	1,400	1,146	685	518	482	437	416	230	165	0	0	0	-	-	-	-
Net cash used in investing activities
-720	-735	-297	-159	-124	-145	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Flows from Financing Activities:
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-488	-451	-437	-416	-230	-165	0	0	0	-	-	-	-
Net proceeds from issuance of common stock and warrants
23,622	25,744	16,785	29,130	29,131	25,693	28,609	18,287	18,287	13,505	19,556	17,673	22,007	13,771	0	0	0	-	-	-	-	-	-	-	-
Net proceeds from issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Proceeds from exercise of common stock warrants
4,815	2,513	2,514	2,514	5	1	0	5	2,239	7,498	0	0	0	-	-	-	-	9,760	0	0	0	-	-	-	-
Payments on finance leases
509	539	378	326	288	160	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of overallotment warrants
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on equipment financings
-	-	-	-	-	-	-	-	-	166	109	82	75	86	0	0	0	-	-	-	-	-	-	-	-
Payments on equipment financings
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Payments on supplier and other third-party financings
-	-	-	-	-	559	589	500	467	465	396	422	431	510	465	319	171	71	62	69	66	192	0	0	0
Payments on credit facility
-	-	-	-	-	1,197	1,696	2,011	1,973	1,934	1,896	1,408	1,322	1,238	0	0	0	-	-	-	-	2,346	0	0	0
Net cash provided by financing activities
30,532	29,662	20,876	33,023	27,640	23,777	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase in Cash
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from borrowings on line of credit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	365	0	0	0
Proceeds from issuance of convertible notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	175	0	0	0
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	25,436	11,936	4,090	3,907	1,290	18,776	18,148	18,357	22,109	20,265	0	0	0
Net increase in Cash
-	-	-	-	-	-	-	-7,431	-4,769	-2,462	5,200	6,248	9,469	-4,211	0	0	0	-	-	-	-	-	-	-	-
Net increase (decrease) in Cash and Cash Equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,722	4,063	8,877	5,295	0	0	0
Supplemental Disclosures of Cash Flow Information:
Cash paid during the period for:
Interest
244	249	413	596	603	605	452	267	329	358	361	396	353	358	378	386	399	405	413	412	352	402	0	0	0
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	2	2	2	0	0	0	-	-	-	-
Gross proceeds from offering
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-